Alberta Investment Management Corp (AIMCo)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9,700
| Closed | -$3.93M | – | 650 |
|
|
2025
Q2 | $3.93M | Sell |
9,700
-20,300
| -68% | -$8.49M | 0.03% | 304 |
|
|
2025
Q1 | $14.9M | Buy |
30,000
+23,600
| +369% | +$12.8M | 0.1% | 147 |
|
|
2024
Q4 | $3.33M | Hold |
6,400
| – | – | 0.02% | 366 |
|
|
2024
Q3 | $3.96M | Buy |
6,400
+2,400
| +60% | +$1.42M | 0.03% | 292 |
|
|
2024
Q2 | $2.21M | Sell |
4,000
-5,100
| -56% | -$2.92M | 0.02% | 334 |
|
|
2024
Q1 | $5.29M | Sell |
9,100
-1,975
| -18% | -$1.11M | 0.05% | 232 |
|
|
2023
Q4 | $5.88M | Buy |
11,075
+2,175
| +24% | +$1.05M | 0.06% | 211 |
|
|
2023
Q3 | $4.5M | Hold |
8,900
| – | – | 0.05% | 279 |
|
|
2023
Q2 | $4.64M | Hold |
8,900
| – | – | 0.04% | 340 |
|
|
2023
Q1 | $5.13M | Buy |
8,900
+5,327
| +149% | +$3M | 0.05% | 332 |
|
|
2022
Q4 | $1.97M | Sell |
3,573
-28,039
| -89% | -$14.9M | 0.02% | 642 |
|
|
2022
Q3 | $16M | Sell |
31,612
-11,200
| -26% | -$6.27M | 0.12% | 177 |
|
|
2022
Q2 | $23.3M | Sell |
42,812
-19,019
| -31% | -$10.5M | 0.17% | 123 |
|
|
2022
Q1 | $36.5M | Buy |
61,831
+26,131
| +73% | +$15M | 0.21% | 99 |
|
|
2021
Q4 | $23.8M | Buy |
35,700
+28,436
| +391% | +$17.8M | 0.15% | 148 |
|
|
2021
Q3 | $4.15M | Sell |
7,264
-3,560
| -33% | -$1.95M | 0.04% | 471 |
|
|
2021
Q2 | $5.46M | Buy |
10,824
+1,260
| +13% | +$595K | 0.05% | 404 |
|
|
2021
Q1 | $4.37M | Buy |
9,564
+5,164
| +117% | +$2.46M | 0.04% | 390 |
|
|
2020
Q4 | $2.05M | Buy |
4,400
+1,600
| +57% | +$750K | 0.02% | 519 |
|
|
2020
Q3 | $1.24M | Buy |
2,800
+900
| +47% | +$372K | 0.01% | 624 |
|
|
2020
Q2 | $688K | Sell |
1,900
-6,900
| -78% | -$2.31M | 0.01% | 760 |
|
|
2020
Q1 | $2.5M | Hold |
8,800
| – | – | 0.04% | 398 |
|
|
2019
Q4 | $2.86M | Buy |
+8,800
| New | +$2.67M | 0.02% | 445 |
|
|
2017
Q1 | – | Sell |
-7,400
| Closed | -$1.04M | – | 903 |
|
|
2016
Q4 | $1.04M | Buy |
+7,400
| New | +$1.09M | 0.01% | 534 |
|
|
2016
Q2 | – | Sell |
-33,800
| Closed | -$4.79M | – | 696 |
|
|
2016
Q1 | $4.79M | Sell |
33,800
-19,900
| -37% | -$2.67M | 0.06% | 253 |
|
|
2015
Q4 | $7.62M | Buy |
53,700
+27,100
| +102% | +$3.61M | 0.09% | 266 |
|
|
2015
Q3 | $3.25M | Sell |
26,600
-51,600
| -66% | -$6.72M | 0.04% | 395 |
|
|
2015
Q2 | $10.1M | Buy |
78,200
+8,000
| +11% | +$1.04M | 0.11% | 242 |
|
|
2015
Q1 | $9.43M | Sell |
70,200
-22,100
| -24% | -$2.85M | 0.1% | 281 |
|
|
2014
Q4 | $11.6M | Buy |
92,300
+20,500
| +29% | +$2.49M | 0.12% | 226 |
|
|
2014
Q3 | $8.74M | Buy |
71,800
+37,900
| +112% | +$4.61M | 0.09% | 287 |
|
|
2014
Q2 | $4M | Sell |
33,900
-17,900
| -35% | -$2.11M | 0.04% | 375 |
|
|
2014
Q1 | $6.23M | Sell |
51,800
-19,200
| -27% | -$2.28M | 0.07% | 332 |
|
|
2013
Q4 | $7.91M | Sell |
71,000
-26,300
| -27% | -$2.62M | 0.1% | 292 |
|
|
2013
Q3 | $8.97M | Buy |
97,300
+36,400
| +60% | +$3.29M | 0.12% | 259 |
|
|
2013
Q2 | $5.43M | Buy |
+60,900
| New | +$5.07M | 0.13% | 145 |
|
Other funds holding TMO
Alberta Investment Management Corp (AIMCo)'s TMO Position: Q3 2025 in Review
Alberta Investment Management Corp (AIMCo) sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 9,700 shares — an estimated $3.93M sold.
Alberta Investment Management Corp (AIMCo) first reported a position in TMO in Q2 2013 and held it in 36 quarters. The position peaked at $36.5M in Q1 2022. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Alberta Investment Management Corp (AIMCo) reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Alberta Investment Management Corp (AIMCo) sold 9,700 Thermo Fisher Scientific shares in Q3 2025, an estimated $3.93M.
- Alberta Investment Management Corp (AIMCo) first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 36 quarters.
- Alberta Investment Management Corp (AIMCo)'s Thermo Fisher Scientific position peaked at $36.5M in Q1 2022.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2025, filed 7 Nov 2025.